706 related articles for article (PubMed ID: 17187823)
1. Conformational stability and domain unfolding of the Von Willebrand factor A domains.
Auton M; Cruz MA; Moake J
J Mol Biol; 2007 Feb; 366(3):986-1000. PubMed ID: 17187823
[TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor without the A2 domain is resistant to proteolysis.
Lankhof H; Damas C; Schiphorst ME; Ijsseldijk MJ; Bracke M; Furlan M; Tsai HM; de Groot PG; Sixma JJ; Vink T
Thromb Haemost; 1997 May; 77(5):1008-13. PubMed ID: 9184419
[TBL] [Abstract][Full Text] [Related]
3. Molecular mapping of the chloride-binding site in von Willebrand factor (VWF): energetics and conformational effects on the VWF/ADAMTS-13 interaction.
De Cristofaro R; Peyvandi F; Baronciani L; Palla R; Lavoretano S; Lombardi R; Di Stasio E; Federici AB; Mannucci PM
J Biol Chem; 2006 Oct; 281(41):30400-11. PubMed ID: 16899464
[TBL] [Abstract][Full Text] [Related]
4. Metal-dependent conformational changes in a recombinant vWF-A domain from human factor B: a solution study by circular dichroism, fourier transform infrared and (1)H NMR spectroscopy.
Hinshelwood J; Perkins SJ
J Mol Biol; 2000 Apr; 298(1):135-47. PubMed ID: 10756110
[TBL] [Abstract][Full Text] [Related]
5. ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.
Dong JF; Moake JL; Bernardo A; Fujikawa K; Ball C; Nolasco L; López JA; Cruz MA
J Biol Chem; 2003 Aug; 278(32):29633-9. PubMed ID: 12775718
[TBL] [Abstract][Full Text] [Related]
6. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.
Nishio K; Anderson PJ; Zheng XL; Sadler JE
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10578-83. PubMed ID: 15249683
[TBL] [Abstract][Full Text] [Related]
7. A3 domain is essential for interaction of von Willebrand factor with collagen type III.
Lankhof H; van Hoeij M; Schiphorst ME; Bracke M; Wu YP; Ijsseldijk MJ; Vink T; de Groot PG; Sixma JJ
Thromb Haemost; 1996 Jun; 75(6):950-8. PubMed ID: 8822592
[TBL] [Abstract][Full Text] [Related]
8. Structure-function relationship of the A1 domain of von Willebrand factor.
Girma JP; Ribba AS; Meyer D
Thromb Haemost; 1995 Jul; 74(1):156-60. PubMed ID: 8578449
[TBL] [Abstract][Full Text] [Related]
9. Unfolding the A2 domain of von Willebrand factor with the optical trap.
Ying J; Ling Y; Westfield LA; Sadler JE; Shao JY
Biophys J; 2010 Apr; 98(8):1685-93. PubMed ID: 20409490
[TBL] [Abstract][Full Text] [Related]
10. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
11. Thermal and urea-induced unfolding of the marginally stable lac repressor DNA-binding domain: a model system for analysis of solute effects on protein processes.
Felitsky DJ; Record MT
Biochemistry; 2003 Feb; 42(7):2202-17. PubMed ID: 12590610
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of partly folded states in the equilibrium unfolding of ervatamin A: spectroscopic description of the native, intermediate, and unfolded states.
Nallamsetty S; Dubey VK; Pande M; Ambasht PK; Jagannadham MV
Biochimie; 2007 Nov; 89(11):1416-24. PubMed ID: 17658212
[TBL] [Abstract][Full Text] [Related]
13. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
Martin C; Morales LD; Cruz MA
J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
[TBL] [Abstract][Full Text] [Related]
14. Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis.
Baldauf C; Schneppenheim R; Stacklies W; Obser T; Pieconka A; Schneppenheim S; Budde U; Zhou J; Gräter F
J Thromb Haemost; 2009 Dec; 7(12):2096-105. PubMed ID: 19817991
[TBL] [Abstract][Full Text] [Related]
15. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors.
Schulte Am Esch J; Robson SC; Knoefel WT; Hosch SB; Rogiers X
Xenotransplantation; 2005 Jan; 12(1):30-7. PubMed ID: 15598271
[TBL] [Abstract][Full Text] [Related]
16. Anion-induced folding of Staphylococcal nuclease: characterization of multiple equilibrium partially folded intermediates.
Uversky VN; Karnoup AS; Segel DJ; Seshadri S; Doniach S; Fink AL
J Mol Biol; 1998 May; 278(4):879-94. PubMed ID: 9614949
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of snake venom toxins interacting with human von Willebrand factor.
Matsui T; Hamako J
Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease.
Jenkins PV; Pasi KJ; Perkins SJ
Blood; 1998 Mar; 91(6):2032-44. PubMed ID: 9490688
[TBL] [Abstract][Full Text] [Related]
19. A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation.
Hauert J; Fernandez-Carneado J; Michielin O; Mathieu S; Grell D; Schapira M; Spertini O; Mutter M; Tuchscherer G; Kovacsovics T
Chembiochem; 2004 Jun; 5(6):856-64. PubMed ID: 15174170
[TBL] [Abstract][Full Text] [Related]
20. Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction.
Schulte am Esch J; Robson SC; Knoefel WT; Eisenberger CF; Peiper M; Rogiers X
Br J Haematol; 2005 Jan; 128(1):82-90. PubMed ID: 15606553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
